Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer - Top-Institutions - MDSpire

Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer

  • By

  • Rowan David

  • Mrunal Hiwase

  • Arman A. Kahokehr

  • Jason Lee

  • David I. Watson

  • John Leung

  • Michael E. O‘Callaghan

  • November 10, 2022

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Radiation Oncology
    • Urologic Oncology
    • Clinical Epidemiology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Radiation Oncology
    • Urologic Oncology
    • Epidemiology

  • #3

    Peter MacCallum Cancer Centre
    Peter MacCallum Cancer Centre

    Melbourne, Victoria

    Key Differentiators

    • Radiation Oncology
    • Urologic Oncology
    • Clinical Research

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Radiation Oncology
    • Urologic Oncology
    • Translational Research

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Radiation Oncology
    • Urologic Oncology
    • Clinical Epidemiology

Original Source(s)

Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer

  • by Rowan David, Mrunal Hiwase, Arman A. Kahokehr, Jason Lee, David I. Watson, John Leung, Michael E. O‘Callaghan

  • November 10, 2022

Related Content

Vacuum-assisted mini-percutaneous nephrolithotomy is associated with lower rates of infectious complications compared to vacuum-cleaner procedure in patients at high risk for infections: a single-center experience

Influence of PSA level at salvage radiotherapy on metastasis-free survival following radical prostatectomy

Biochemical Tumor Markers: Are New Testing Guidelines Fit for Purpose?

CLSI guidance achieves technical excellence but has some questionable omissions, says Mustafa Barbhuiya